Design and Development of a Mobile App to Improve Adherence to Pre-exposure Prophylaxis in Men Who Have Sex With Men
- Conditions
- HIV InfectionsPre-Exposure Prophylaxis
- Interventions
- Behavioral: mobile app to improve adherence to PrEP self-management
- Registration Number
- NCT04248790
- Lead Sponsor
- National Cheng Kung University
- Brief Summary
This study is testing feasibility and acceptability of a theoretically based mobile application (app), UPrEPU, to increase adherence to pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) to prevent human immunodeficiency virus (HIV).
- Detailed Description
This study aims to develop an effective mobile application (app), UPrEPU to recognize the factors and decisions that affect PrEP adherence in high-risk populations to improve PrEP adherence. Key components of the app include a sex/PrEP diary using ecological momentary assessment to facilitate accurate data collection; PrEP taking reminder; HIV and sexually transmitted infections (STI) testing information and reminders; HIV and PrEP information and videos; geo-location.
After eligible PrEP candidates agree to participate in the study, we will ask participants to install the app. Then, we will begin to collect their sexual diary and PrEP taking log via ecological momentary assessment. Participants will also complete monthly assessments. The monthly follow-up will test HIV/STI and drug concentration. The participants will be interviewed for difficulties when they use our app and giving feedback on it.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 35
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Experimental: the mobile App mobile app to improve adherence to PrEP self-management Participants in the intervention arm will receive access to all the app capabilities. The app features include information on HIV testing locations, sex and PrEP diary and reminder of taking PrEP.
- Primary Outcome Measures
Name Time Method Efficacy of adherence monitoring 4 months Measuring the Tenofovir (TDF) and Emtricitabine (FTC) drug concentration in dried blood spot (DBS) samples to compare with self-report data
Usability 4 months Scores on system usability scale (SUS) for this app at the first month and the fourth month.
Feasibility: data based on the app analytics 4 months 1. Frequency of app log-in;
2. Use of app components such as PrEP-taking and sex behavior reports;
3. Duration of app use
- Secondary Outcome Measures
Name Time Method Feasibility: data from qualitative interviews 4 months 1. any technical challenges participants may have encountered;
2. recommendations for the app improvement;
3. users' satisfaction and comfort in using this app
Trial Locations
- Locations (3)
Taipei city hospital (Renai Branch)
🇨🇳Taipei, Taiwan
National Cheng Kung University Hospital
🇨🇳Tainan City, Tainan, Taiwan
Taipei Veterans General Hospital
🇨🇳Taipei, Taiwan